Nasibah Azme

Dr. Nasibah Azme

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in Cureus
Verified
Journal Article
Open access
PDF file
NKNurin Yasmin Mohd Khairudin
Nurin Yasmin Mohd Khairudin
NANasibah Azme
Nasibah Azme
NNNurdiyana Nasrudin
Nurdiyana Nasrudin
SKSiti Aznida Ab Karim
Siti Aznida Ab Karim
Celastrol is a pentacyclic tripterine sourced from Tripterygium wilfordii hook root. Celastrol can exert certain biological functions such as antitumor, anti-inflammatory, and antiproliferative properties. Celastrol was shown from the previous literature to be capable of attenuating many fibrotic diseases. As the effects of various fibrotic diseases such as atherosclerosis, cancer, and ischemia affect more people with devastating repercussions, this warrants celastrol to be exploited as a phytotherapeutic drug. The purpose of this study is to review previous research and identify the proposed therapeutic mechanisms of celastrol in fibrotic diseases focusing on both the in vitro and in vivo experimental models. A systematic literature search on Web of Science (WoS), Scopus, and ScienceDirect that included articles published between 2012 and 2022 was carried out using the keywords “celastrol”, “tripterine”, “fibrotic disease”, and “fibrosis”. After screening the initial search yield of 405 articles, 25 articles were included in this review. The study findings summarize the potential therapeutic mechanism of celastrol in the attenuation of fibrotic diseases in in vivo and in vitro experimental models. It shows that celastrol is useful as a treatment means. However, more studies are needed on the effects of celastrol on humans to carry out clinical trials to verify the long-term benefits of celastrol.

30 March 2026 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
SZSiti Bazilah Zulkefli
Siti Bazilah Zulkefli
FMFathimah Mohamad
Fathimah Mohamad
NNNurul Alimah Abdul Nasir
Nurul Alimah Abdul Nasir
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NANasibah Azme
Nasibah Azme

30 January 2025 in Environment-Behaviour Proceedings Journal
Verified
Journal Article
Open access
PDF file
NANasibah Azme
Nasibah Azme
WZWan Nor I'zzah Wan Mohamad Zain
Wan Nor I'zzah Wan Mohamad Zain
SESusi Endrini
Susi Endrini
Work-life balance (WLB) among female healthcare professionals (FHPs) in Asia is compromised by intersecting professional and family responsibilities, impacting their quality of life (QOL) and job satisfaction. This thematic review of 21 studies across seven Asian countries identifies key factors affecting WLB and QOL, including excessive workloads, cultural expectations, mental health strain, gender inequity, and insufficient workplace support. Eight themes emerged, highlighting systemic challenges. Recommendations include flexible policies, enhanced mental health resources, and resilience-building interventions. Addressing these issues is vital for improving FHPs' well-being and sustaining healthcare services in Asia.

30 October 2024 in International Journal of Social Science Research
Verified
Journal Article
Open access
PDF file
WZWan Najwa Wan Mohd Zohdi
Wan Najwa Wan Mohd Zohdi
NANasibah Azme
Nasibah Azme
Humanities are essential to medical training as they enhance scientific understanding with compassion, ethical decision-making and cultural sensitivity, promoting holistic health care providers. Integrating humanities into medical curricula emphasizes their impact on emotional intelligence, narrative medicine, communication skills, and ethical judgment. Based on diverse methodologies and theoretical frameworks such as narrative medicine and emotional intelligence, this review demonstrates how humanities enhance observational skills, empathy, and professionalism. Innovative strategies that blend medical education with the humanities, such as theater-based learning, art-based observation, and museum visits, are currently being adopted into medical training. Nonetheless, various implementation barriers, such as inadequate assessment tools, excessive workload, and skepticism, affect the successful integration of humanities into medical practice. From a global perspective, disparities in humanities integration between high-income and low-income countries become apparent, highlighting the need for scalable and culturally adapted solutions. Further studies focusing on longitudinal aspects, standardized assessment tools, and approaches to improve accessibility in resource-limited settings are warranted to fill these gaps. This review adds to the argument that the humanities are critical to medical education for building competent, compassionate, and ethically grounded healthcare providers.

25 July 2026 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
NINur Iffah Ishak
Nur Iffah Ishak
RSRosfaiizah Siran
Rosfaiizah Siran
WZWan Nor I’ZZah Wan Mohamad Zain
Wan Nor I’ZZah Wan Mohamad Zain
NANasibah Azme
Nasibah Azme
: Endothelial-to-Mesenchymal Transition (EndMT) is a significant contributor to Blood- Brain Barrier (BBB) dysfunction in various brain diseases. The majority of current therapies, aimed at reducing BBB dysfunction, focus on preventing inflammation or stabilizing tight junctions. In most cases, these therapies do not provide adequate or long-lasting vascular protection. Endothelial cells undergo phenotypic programming, losing their barrier-forming capacity and developing features of mesenchymal and extracellular matrix-producing cells as the disease progresses. The change leads to chronic vascular leakage, neuroinflammation, microvascular fibrosis, and dysfunctional neurovascular coupling. Several upstream stimuli, including inflammatory cytokines, TGF-β/BMP-Smad signaling, and oxidative damage, converge to drive EndMT within the distinctive, specialized environment of the brain endothelium. Ischemic stroke, multiple sclerosis, cerebral cavernous malformations, arteriovenous malformations, glioblastoma, brain metastasis, and Alzheimer's disease indicate that EndMT is not a rare or unique process but a shared and common pathologic process that may result in disease progression and eventual resistance to treatment. Recent single-cell and spatial transcriptomic data have shown that partial EndMT states exist and may be precursors to irreversible microvascular remodeling. It is necessary to identify therapeutic approaches that go beyond short-term stabilization of the BBB and target the molecular programs underlying the loss of endothelial identity. This review synthesizes mechanistic, disease-related, and therapeutic evidence indicating that EndMT is a leading cause of BBB failure and highlights therapeutic opportunities for targeting this endothelial plasticity in brain diseases.

23 December 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NKNurin Yasmin Mohd Khairudin
Nurin Yasmin Mohd Khairudin
AAAwla Mohd Azraai
Awla Mohd Azraai
RSRosfaiizah Siran
Rosfaiizah Siran
NANasibah Azme
Nasibah Azme
Genistein is an isoflavone phytoestrogen that is considered a nutraceutical compound found in soybean. The mimicking of estrogen effects includes the ability to bind to the intracellular and cell membrane receptors of estrogen and exert biological functions like antitumor, anti-inflammatory, anti-oxidative, and antiproliferative properties. With more studies focusing on the therapeutic effect of genistein, both in vitro and in vivo , it is evident that genistein acts through multiple pathways including anti-apoptotic, anti-inflammatory, and anti-oxidative. As the effects of stroke are affecting more people and causing devastating repercussions, this warrants genistein to be utilized as a therapeutic drug. Therefore, further studies are due on the effects of genistein on humans so that clinical trials can be carried out for long-term benefits. This review encompasses various studies regarding the potential neuroprotective effects of genistein on cerebral stroke, examining both in vitro and in vivo experimental models. Four database searches: Web of Science (WoS), Scopus, PUBMED and Science Direct were searched from 1 st January 1999 until 31st October 2025. The initial datasets identified through the database search yielded a total of 549 publications and 341 publications were finalized after removing duplicates. In the initial screening, a total of 293 studies were excluded due to their irrelevance to the main objective of this study. After assessing the suitability of the studies and following the PRISMA guidelines, a total of 31 articles were found to be suitable and systematically reviewed. Findings demonstrated the major mechanistic pathways involved in the therapeutic action of genistein are anti-apoptotic, anti-inflammatory, and anti-oxidative. Each of these mechanisms is governed by specific pathways, which will be thoroughly discussed, indicating that genistein can be effective as a therapeutic drug in ischemic stroke.